Get Involved
Contact Your Congressional Representative to Support Ibogaine Legislation:
Your voice matters in the fight for ibogaine research and access. Use the tool below to find your U.S. Senators and Representatives and tell them you support FDA-approved clinical trials for ibogaine. Educating lawmakers about ibogaine’s potential to address substance use disorder and mental health conditions is crucial to advancing research and expanding access.
Advocacy & Action
Support ibogaine research and awareness by:
Contacting local and state representatives to express support for ibogaine research initiatives.
Participating in public forums and discussions to raise awareness about ibogaine’s potential benefits.
Collaborating with organizations like the Texas Ibogaine Initiative to promote policy changes supporting clinical trials and research funding.
Events & Conferences
Stay informed about upcoming ibogaine-related events:
Psychedelic Science Conference – Hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), this event covers a range of topics, including ibogaine research. Find out more.
Donations & Support
Your donation helps fuel education, advocacy, and access efforts around breakthrough therapies like the ones supported by Texas House Bill 3717.
Together, we can bring hope to veterans, first responders, and families facing treatment-resistant trauma and substance use struggles.
Every dollar counts. Every voice matters.
https://donate.etcf.org/americans-for-ibogaine
Share Your Story
If you have a story of hope and healing using ibogaine, we invite you to share it with our community
Texas Clinical Trial Interest Form
⚠️ IMPORTANT DISCLAIMER
Submitting this form does not guarantee inclusion in any clinical trial.
Americans for Ibogaine is an independent advocacy organization and is not directly affiliated with, nor responsible for, the administration or selection processes of any clinical trials related to ibogaine or any other treatment.
This form is for informational and outreach purposes only. By submitting, you acknowledge that participation decisions are made solely by the clinical research teams overseeing their respective studies.